BUY Price at COB 1 October p 52-week range 39-68p. CSF Group CX6 restructuring. Technology.

Similar documents
IndigoVision Group (IND LN)

DX (Group) plc* Industrial Transportation. Successful HMPO tender improves forecast certainty. Price 17.75p. Price Performance. Financial Forecasts

One51 Plc One51 Management focused on creating shareholder value

E-FIT trial results indicate no clinical improvement

Carr s Group. Diversification continues to give resilience. PBT up for H117 as UK farmers gain in confidence

Angel Mining. Update. Investment summary: First gold. Price 7.25p Market Cap 22m. Future developments at Nalunaq

City of London Investment Group*

FLASH NOTE EQUITY RESEARCH. OUTPERFORM Price target 6.40 Price Elanix Biotechnologies AG (ELN-DE) Updates from webcast include financial outlook

Eddie Stobart Logistics

Shanks Group. Global commodity crisis offsetting progress. Netherlands Commercial progress encouraging

PALACE CAPITAL PLC (PCA.L)

Buy Primary Health Properties #

Platform Laid for Sustained Growth

OMAX.BO 1QFY13 Result Impressive uptick in margins. Promoters 89 grow. Continued focus on plotted development and low rise (with less construction

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY?

Regional REIT. Retail eligible bond 4.5% Regional markets have remained robust. Retail eligible bond offering. Launch of bond issue.


TerraNet Holding. Irons in the fire. Five new strategic development orders won in Q317. Cash flow burn reflecting multi-project activity

K3 Business Technology

A pivotal year

EQUITY RESEARCH. Reckitt Benckiser, French s Food business sold. Share Price: 7,936p Target Price: 8,000p* (+1%) 19 July 2017

Michelmersh Plc. Michelmersh Baked in Value. Michelmersh has a market cap of 57m with no debt. At the half

ContextVision. Expecting solid results and awaiting progress update on research program

K3 Business Technology Update on preliminary results

OTC Markets Group. Record quarterly revenues. Q115 Corporate services revenue rises 54% Operating expenses rise 18% in Q115.

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

Paysafe Group. Growth normalises. Growth moderates in H117. Pro forma financials show potential impact of deals

Mondo TV. YooHoo! Netflix deal drives significant upgrades. Global deal with Netflix, new Chinese productions. Significant increase to five-year plan

CITY OF LONDON INVESTMENT GROUP

TXT e-solutions. Strong cash flow supports dividend boost. PACE acquisition boosts FY16 performance. Minor changes to earnings forecasts

Circle Property. Lifting estimates again. Revaluation gains and strong rent growth. Upside potential from refurbished assets

Melbana Energy (MAY AU) 07 August 2018

Falanx Group Ltd. 16 October

Schoeller Bleckmann. Oilfield Services 9 March 2012 BUY BUY. Recent weakness presents good opportunity. Flash Note (SBO AV)

CITY OF LONDON INVESTMENT GROUP

STMicroelectronics N.V.

Bintulu Port Holdings Bhd

Centrale del Latte d'italia

XP Power. Strong demand drives record performance in H1. H118 sees continuation of strong growth

Silicon Works (108320)

S&P Dow Jones Disclaimer

Key estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9,

Marti REIT. Update. Investment summary: Building the foundations. Group finances: Early stage development volatility

Century Plyboards (India)

Interim Announcement Presentation

BURFORD CAPITAL. Financial summary and valuation

GB Group. PCA acquisition an excellent fit. PCA adds SME reach to address intelligence services. Earnings enhancing despite growth investment

Ps&C. Still battling. NOT RATED (previously HOLD) Australia

GLG Life Tech. Luo Han Guo drives revenue growth. Tate & Lyle LHG contract boosts top line. H3 and H4 leaf should improve stevia margins

Evolva. EverSweet. Delivering on the new strategy. FY17 results. Valuation: Fair value of CHF0.60 per share. FY17 results.

GFT Group. IT services pure-play focused on banks. Disposal of emagine. Acquisition of Adesis Netlife SL. Forecasts: Adjusted for effects of the deals

SciSys. Update. Investment summary: A very good December. Market Cap 14m. Investment case: Focus on margin expansion

JackpotJoy plc. A transformational year. Revenue and EBITDA slightly ahead of estimates. Strong operating cash flow dividends from 2019

Sareum Holdings plc. Paper on lead candidate CHK1 published in high-impact journal. Update. 23 July 2015 HYBRIDAN LLP

F L A S H. Tanfield Group. One step ahead. Event. Impact. Recommendation. Refer to important disclosures starting on page 6

BTO: Q2/15 Earnings Preview

KEFI Minerals. Counting down to production. Outstanding matters. Valuation: 6.55p/sh in FY18 rising to 7.21p/sh in FY19.

EQUITY RESEARCH. Royal Dutch Shell B, Attractively Valued - Buy. Share Price: 2,202p Target Price: 2,500p (+14%) 21 September 2017

Centrale del Latte d'italia

Century Plyboards (India)

Echelon Retail Could Be Delayed; Broader Implications Possible

GOLDMAN SACHS (JERSEY) LIMITED (incorporated with limited liability in Jersey) GOLDMAN SACHS EUROPE (incorporated with unlimited liability in England)

FLASH NOTE Welspun India 31 Jan 17

Key estimate revision. Year FY14 23,28,609 3,48,027 1,40, FY15E 25,74,029 3,94,133 1,69,

Embargoed until 7am 21 November CSF Group plc ( CSF or the Group ) HALF-YEAR RESULTS For the Six Months Ended 30 September 2014

Key estimate revision. Financial summary. Year

R-Power Suzlon. JSW Energy NHPC

LUCISANO MEDIA GROUP. New partner for Lucisano. Buy (maintained) Company Update

TAV Airports EARNINGS REVIEW 4Q17. Bottom-line below consensus BUY TRY22.90

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Regional REIT. Asset growth and refinancing completed. Further portfolio growth and diversification. Acquisition benefit offset by underlying revision

Piteco. Bold entry into the US marketplace. Acquisition of US payments software provider. Forecasts: FY18 revenues rise by 34%, EPS by 12%

Q4 EARNINGS REPORT Welspun India 25 Apr 17

Century Plyboards. Result Update UNDER REVIEW. Ply revenue surprise, so does low interest cost AMBIT INSIGHTS

Bakkavor Finance (2) plc

4 YEAR CHF 3.20% CPN CAPITAL PROTECTED NOTE LINKED TO EUR/CHF

YG Entertainment (122870)

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Sirius Minerals. Update. Investment summary: SM2 drill result. Price 25.5p Market cap 263m. Two separate seams of massive polyhalite

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24.

TXT e-solutions. Steady growth in Q3. Growth for both businesses in Q3. Outlook and changes to forecasts

HUTCHISON WHAMPOA LIMITED ( 和記黃埔 )

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

K3 Business Technology

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Crowd Mobile (CM8) A Strong FY17 Result. 24 March Bell Potter Small Cap Team

INTERIMS: ADEPT TELECOM

Ambuja Cements. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.225. Rs. 195

AMINO TECHNOLOGIES TECHNOLOGY HARDWARE AND EQUIPMENT

HUTCHISON WHAMPOA LIMITED (

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium.

Carr's Group. Profits dip as expected with FY18 recovery underway. FY17 impacted by external factors. FY18 recovery underway

CSF Group plc ( CSF or the Group ) HALF-YEAR RESULTS For the six months ended 30 September 2016

Savaria Corporation. Q2/17 Results. Span contribution begins; guidance revised (unsurprisingly) upwards HIGHLIGHTS. The NBF Daily Bulletin

Adani Ports & SEZ Rating: Target price: EPS:

Daewoo E&C ( KS) WHAT S THE STORY?

RELIANCE INDUSTRIES LIMITED

StockReports+ User Guide

Transcription:

70 65 60 55 50 45 40 35 C SF G R O U P O N D J F M A M J J A S So u r c e : T h o m s o n R e u te r s D a ta s tr e a m Technology 2 October 2012 International Update CSF Group CX6 restructuring CSF has announced that the major customer behind the planned build of CX6 has significantly up-scaled their plan for the build in Johor, Malaysia. This should increase the volume of project work for CSF but the need for re-design, new planning permission etc means that revenues on the project will move out of FY13 (year-end March). The net result is that our FY13 EPS forecast falls from 5.2p to 1.4p. Importantly, our data centre rental forecasts are unchanged and the Group is on-track with discussions to fill CX5 B. We still have CSF generating cash in FY13, finishing the year with over 17m of net cash. Upgrade in size of CX6. The data centre had been specified to 70,000 sq ft for a major existing customer. A proposal with preliminary designs had been submitted and CSF had been awaiting a formal award of the project. The project offers sizeable consultancy project fees and potentially ongoing maintenance fees (but no recurring rental income). The customer has now decided they wish to increase the size of the data centre to 120,000 sq ft. This is clearly positive in terms of volume of work for CSF and the overall demand backdrop for DC space in the region. However, the additional design and planning work requirements means a delay in the fit-out revenues for CSF. Similarly, it had been hoped that CX Singapore (a planned 100,000 sq ft JV CSF is negotiating with a Singaporean property developer and a major Asian conglomerate) could be pulled forward to utilise consultants in FY13 but again the scale of the opportunity under discussion is changing. Forecasts. Importantly, there are no changes to the higher value core Data Centre Rental EBITDA in FY13 or FY14. There are a number of on-going discussions with potential customers for CX5 block B (c 6m of additional EBITDA fully-let). However, we have significantly cut our fit-out Design & Development (D&D) revenues. Our Fit-out sales assumption in FY13 falls from MYR133m to MYR30m and Consultancy sales from MYR12m to MYR2m. The net result is our FY13 Adjusted EPS forecast falls to 1.4p (5.2p). We now forecast net cash increases from 10.6m to 17.4m (previously 26.1m) including the recently collected 17m from the completed sale and lease-back of CX5. Our FY13 dividend estimate remains unchanged. While it is not covered by earnings it is over 5x covered by our cash forecast. We have made more modest reductions to our FY14 D&D forecasts until we know the exact timing of major project work (EPS falls from 6.4p to 5.2p). The set-back in earnings is disappointing but the Group has world class data centre assets, backed by longterm agreements with blue-chip tenants. We believe the DC assets and rental stream is worth 60p+ a share in the context of global sector M&A. Forecasts and Ratios Yr end March( m) 2011A 2012A 2013e 2014e Revenue 23.3 42.4 28.3 47.5 EBITDA 10.4 12.7 3.6 10.5 PBT Adj 10.3 12.0 2.4 10.2 EPS Adj 6.2 6.0 1.4 5.2 P/E 7.2 7.4 31.6 8.5 DPS 1.90 2.00 2.00 2.00 Net Cash ( m) 16.1 10.6 17.4 22.5 Under the Markets in Financial Instruments Directive and the Financial Services Authority Conduct of Business rules this document is a Marketing Communication. Cenkos Securities plc is authorised and regulated by the Financial Services Authority and is a member of the London Stock Exchange. Registered office: 6.7.8 Tokenhouse Yard, London EC2R 7AS Registered in England and Wales No.5210733 BUY Price at COB 1 October 2012 44p 52-week range 39-68p Ticker: CSFG Share Price Performance Source: Thomson Datastream Performance (%) 1m 3m 12m Absolute -2.2 1.1-20.9 Relative to FTALLSH -4.0-3.5-30.7 Stock Data Market cap ( m) 71 Shares outstanding (m) 160 Key Indicators Net debt/equity(%) n/a EBIT margin (%) 10.7% Activities CSF is a leading designer and manager of Data Centres in Malaysia and across S.E.Asia Directors Dato Ting Adrian Yong Lee, King Loon Chairman CEO CFO Significant Share Holders Directors 47% Legal and General 13% Standard Life 4% Contacts Andy Bryant Analyst 0207 397 1970 abryant@cenkos.com Jason Holden Analyst 0207 397 1971 jholden@cenkos.com Julian Morse Sales 0207 397 1931 jmorse@cenkos.com C S F G 0 1 /1 0 /1 2

Financials Table 1: Divisional forecasts 2010 2011 2012 2013e 2014e Revenue Data Centre Rental 7.9 12.1 15.2 20.1 23.4 Maintenance 1.7 1.7 1.7 1.9 2.0 Design and Development 4.8 9.4 25.6 6.4 22.0 Divisional EBITDA Data Centre Rental 2.3 2.5 4.0 4.0 5.5 Maintenance 0.8 0.5 0.5 0.7 0.7 Design and Development 0.9 3.9 8.8 0.4 6.0 Margin Data Centre Rental 29% 21% 27% 20% 24% Maintenance 48% 28% 33% 35% 35% Design and Development 20% 42% 34% 6% 27% Table 2: P&L Year end 31 March 2011 2012 2013e 2014e PROFIT & LOSS Revenue 23.3 42.4 28.3 47.5 EBITDA 10.4 12.7 3.6 10.5 Depreciation (.3) (0.6) (0.5) (0.5) Adjusted Operating Profit 10.1 12.1 3.0 10.0 Exceptionals 0.1 (0.5) (0.2) (0.2) Share based payments (0.2) (0.3) (0.3) (0.3) Associate / Equity income 0.0 (0.4) (1.2) (0.6) Operating Profit Rptd 10.0 10.9 1.4 9.0 Net Interest 0.3 0.3 0.5 0.8 Other (0.1) 0.1 0.0 0.0 Profit Before Tax Reported 10.2 11.2 1.9 9.7 Exceptionals (0.1) 0.5 0.2 0.2 Share based payments 0.2 0.3 0.3 0.3 Profit Before Tax Adj 10.3 12.0 2.4 10.2 Tax (0.4) (2.3) (0.9) (2.9) Profit After Tax (adj) 9.9 9.7 1.5 7.2 Profit After Tax (Rptd) 9.8 8.9 1.0 6.8 Average Number of Shares Outstanding (m) 160.0 160.0 160.0 160.2 EPS - Underlying/Adjusted (p) 6.2 6.0 1.4 5.2 EPS - Underlying /Tax Adjusted (assumes 30% rate) 5.6 1.5 5.1 EPS - Rptd (p) 6.1 5.6 0.6 4.2 Dividend per share (p) 1.90 2.00 2.00 2.00 2

Table 3: Cashflow 2011 2012 2013e 2014e Operating Cash Flow (2.8) 4.5 7.0 7.8 Net Interest 0.5 0.2 0.5 0.8 Tax 0.0 (2.1) (0.8) (2.6) Capex (3.6) (1.3) (3.2) (1.8) Acquisitions/disposals 10.6 0.0 (0.3) 0.0 Financing 0.0 0.0 0.0 0.0 Development partner loans (12.1) (3.6) 7.0 4.4 Dividends 0.0 (3.0) (3.3) (3.5) Other 0.0 (0.1) 0.0 0.0 Net Cash Flow (7.4) (5.5) 6.9 5.0 Opening net cash / (debt) 16.1 10.6 17.4 Closing net cash / (debt) 16.1 10.6 17.4 22.5 3

Disclosures Analyst Certification The analyst(s) responsible for preparing this research report or sections of this report, in whole or in part, hereby certify/ies that, with respect to any and all of the securities or issuers that the analyst(s) cover(s) in this report, the views expressed in this report accurately reflect his/her/their personal views. In addition, no part of the research analyst's compensation was, is, or will be directly or indirectly, related to the specific recommendations or view expressed in this report or summary. Recommendations definitions Definition of research recommendations for issuers listed on the London Stock Exchange. Expected returns are bench marked against performance of the FTSE All Share Index as follows: BUY is an expected return ahead of market performance; HOLD is an expected return in line with market performance; and SELL is an expected return which is below market performance. Definition of research recommendations for issuers admitted to trading on AIM. Expected returns are bench marked against performance of the AIM All Share Index as follows: BUY is a total return which is above 10% of market performance; HOLD is a return of between -10% and +10% of market performance; and SELL is a total return which is below 10% of market performance. Temporary movements by stocks across the boundaries of these categories due to share price volatility will not necessarily trigger a recommendation change. All recommendations are based on 12 month time horizon unless otherwise stated. For recommendation history on a specific stock, please contact the appropriate Cenkos analyst or your Cenkos contact on 020 7397 8900. Conflicts of Interest Disclosures CSF Group PLC 2, 6, 8, 9, 10, 11 Legend 1. The analyst responsible for, and/or persons involved in the preparation of, the research has a beneficial interest in the shares of this issuer. 2. The analyst responsible for this report may have his/her remuneration linked to investment banking transactions performed by Cenkos. 3. A director, officer or employee of Cenkos or a member of his/her household, is an officer, director, or serves as an adviser or board member of the issuer. 4. As at the date of this research, Cenkos has a beneficial interest exceeding 5% of the total issued share capital in the issuer. 5. As at the date of this research, the issuer has a beneficial interest exceeding 5% of the total issued share capital of Cenkos. 6. Cenkos acts as a market maker or liquidity provider in relation to securities issued by the issuer. 7. Cenkos has been the lead manager or co-lead manager in a public offering of the issuer s financial instruments during the previous 12 months. 8. Cenkos has received compensation from the issuer for the provision of investment banking or financial advisory services within the previous 12 months. 9. Cenkos is party to an agreement with the issuer relating to the provision of research coverage for this issuer and Cenkos may receive remuneration for such service. 10. Cenkos acts as a corporate broker to this issuer. 11. Cenkos acts as a nominated adviser, financial adviser or as a sponsor to the issuer in the UK. 12. Any other specific disclosures.

DISCLAIMER This communication is NON-INDEPENDENT RESEARCH AND A MARKETING COMMUNICATION and is issued in the UK by Cenkos Securities PLC ( Cenkos ), which is authorised and regulated by the Financial Services Authority ("FSA") and is a member of the London Stock Exchange. It is intended for the sole use of the person to whom it is addressed and is not intended for private individuals or those classified as Retail Clients. This document is for persons who are Eligible Counterparties or Professional Clients only and is exempt from the general restriction in section 21 of the Financial Services and Markets Act 2000 on the communication of invitations or inducements to engage in investment activity on the grounds that it is being distributed in the United Kingdom only to persons of a kind described in Articles 19(5) (Investment professionals) and 49(2) (High net worth companies, unincorporated associations etc), of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended). It is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. Laws and regulations of other countries may also restrict the distribution of this report. Persons in possession of this document should inform themselves about possible legal restrictions and observe them accordingly. Any investment to which this document relates is available only to such persons, and other classes of person should not rely on this document. For the purposes of UK regulation, Cenkos produces non-independent research which is a marketing communication under the FSA Conduct of Business rules. Non-independent research has not been prepared in accordance with the legal requirements to promote independence of investment research nor is it subject to the prohibition on dealing ahead of the dissemination of investment research. This document has been prepared and issued by Cenkos on the basis of publicly available information, internally developed data and other sources believed to be reliable. Share price performance graphs are sourced from Proquote International and Thomson Reuters Datastream. The information contained in this publication was obtained from various sources believed to be reliable, but has not been independently verified by Cenkos. Cenkos does not warrant the completeness or accuracy of such information and does not accept any liability with respect to the accuracy or completeness of such information, except to the extent required by applicable law. Any opinions, projections, forecasts or estimates in this report are those of the author only, who has acted with a high degree of expertise. They reflect only the current views of the author at the date of this report and are subject to change without notice. Cenkos has no obligation to update, modify or amend this publication or to otherwise notify a reader or recipient of this publication in the event that any matter, opinion, projection, forecast or estimate contained herein, changes or subsequently becomes inaccurate, or if research on the subject company is withdrawn. The analysis, opinions, projections, forecasts and estimates expressed in this report were in no way affected or influenced by the issuer. The author of this publication benefits financially from the overall success of Cenkos. This publication is a brief summary and does not purport to contain all available information on the subjects covered. Further information may be available on request. This report may not be reproduced for further publication without the prior written permission of Cenkos. This publication is for information purposes only and shall not be construed as an offer or solicitation for the subscription or purchase or sale of any securities, or as an invitation, inducement or intermediation for the sale, subscription or purchase of any securities, or for engaging in any other transaction. The investments referred to in this publication may not be suitable for all recipients. Recipients are urged to base their investment decisions upon their own appropriate investigations that they deem necessary. Any loss or other consequence arising from the use of the material contained in this publication shall be the sole and exclusive responsibility of the investor and Cenkos accepts no liability for any such loss or consequence. In the event of any doubt about any investment, recipients should contact their own investment, legal and/or tax advisers to seek advice regarding the appropriateness of investing. Some of the investments mentioned in this publication may not be readily liquid investments. Certain transactions, including those involving futures, options, and high yield securities, give rise to substantial risk and are not suitable for all investors. Investors should be aware of the additional and special risks associated with securities and investments in emerging markets. Consequently it may be difficult to sell or realise such investments. The past is not necessarily a guide to future performance of an investment. The value of investments and the income derived from them may fall as well as rise and investors may not get back the amount invested. Some investments discussed in this publication may have a high level of volatility. High volatility investments may experience sudden and large falls in their value which may cause losses. International investing includes risks related to political and economic uncertainties of foreign countries, as well as currency risk. To the extent permitted by applicable law, no liability whatsoever is accepted for any direct or consequential loss, damages, costs or prejudices whatsoever arising from the use of this publication or its contents. Cenkos has written procedures designed to identify and manage potential conflicts of interest that arise in connection with its research business and its production. Cenkos research analysts and other staff involved in issuing and disseminating research reports operate independently of Cenkos Investment Banking business. Information barriers procedures are in place between the research analysts and staff involved in securities trading for the account of Cenkos or its clients to ensure that price sensitive information is handled according to applicable laws and regulations. Cenkos may be remunerated by a company for writing research on that company, in which case, a specific disclosure will be made in the relevant research report. Each company understands and agrees that the analysis, opinions, projections, forecasts and estimates expressed in such research reports will be honest and unbiased in compliance with Cenkos Conflicts of Interests and Research Policies and will in no way be influenced by any remuneration received by Cenkos from the company. For further details, please see Cenkos Conflicts of Interest Policy available on our website at.